Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...

A fundamental shake-up of how we screen women for breast cancer could save more lives from the disease. Here are some options ...

Synthetic Biology is advancing the use of microorganisms as cancer therapies, with scientists engineering bacteria to boost antitumor immunity and deliver ...

In this discussion with Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, she illustrates how Vanderbilt works to ...

GE HealthCare Technologies Inc. GEHC, on Thursday, announced the launch of the Invenia Automated Breast Ultrasound (ABUS) ...

The FDA has granted traditional approval to Keytruda (pembrolizumab) in combination with trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma.

University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggressive form of breast cancer.

In Kenya, due to the lack of robust screening, many women only seek medical attention when they notice advanced symptoms.

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

Roughly 200 million women around the world suffer from endometriosis, a condition that causes tissue from the lining of the uterus to grow in places outside of the uterus.

Nicola Heart believed that holding her newborn babies as they died would be the most difficult experience of her life. That ...